Companies Like Deciphera Pharmaceuticals (NASDAQ:DCPH) Are In A Position To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Source: yahoo.com
Deciphera Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Deciphera Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Deciphera Pharmaceutical Today - Breaking & Trending Today
Financial Comparison: KALA BIO (NASDAQ:KALA) & Deciphera Pharmaceuticals (NASDAQ:DCPH)
KALA BIO (NASDAQ:KALA – Get Free Report) and Deciphera Pharmaceuticals (NASDAQ:DCPH – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Institutional and Insider Ownership 24.0% of KALA […]
Source: wkrb13.com
Deciphera Pharmaceuticals, Inc. to Post FY2026 Earnings of ($1.25) Per Share, Zacks Research Forecasts (NASDAQ:DCPH)
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Zacks Research issued their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a research note issued to investors on Tuesday, February 27th. Zacks Research analyst A. Chakraborty anticipates that the company will post earnings per share of ($1.25) for the year. The consensus estimate for Deciphera […]
Source: dailypolitical.com
Analysts Issue Forecasts for Deciphera Pharmaceuticals, Inc.'s FY2026 Earnings (NASDAQ:DCPH)
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Equities researchers at Zacks Research issued their FY2026 earnings per share estimates for Deciphera Pharmaceuticals in a research report issued on Tuesday, February 27th. Zacks Research analyst A. Chakraborty anticipates that the company will post earnings of ($1.25) per share for the year. The consensus estimate for […]
Source: tickerreport.com
Q1 2024 EPS Estimates for Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Boosted by HC Wainwright
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Free Report) – Research analysts at HC Wainwright raised their Q1 2024 EPS estimates for Deciphera Pharmaceuticals in a report issued on Wednesday, February 7th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings of ($0.63) per share for the quarter, up from their previous estimate […]
Source: tickerreport.com